All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version).
To receive Global Research’s Daily Newsletter (selected articles), click here.
Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
***
Guest is Karen Kingston, a Biotech Analyst and med-legal advisor with over 20 years of experience driving blockbuster commercialization efforts for medical devices and prescription therapies. She was once a Cardiovascular Sales Representative for the Northeast Region of New York at Pfizer.
This session is about the crossover study in which Pfizer injected as many infants and toddlers as parents would basically allow.
The results suggest devastating consequences of this study: stunningly few “subjects” aged 6 months to 4 years showed up for their first study visit, which was scheduled a week after the third dose.
According to the EUA document, many infants and toddlers suffered epilepticus, meaning multiple seizures per day, some of which were associated with permanent brain damage confirmed by EEG.
*
Note to readers: Please click the share buttons above or below. Follow us on Instagram and Twitter and subscribe to our Telegram Channel. Feel free to repost and share widely Global Research articles.
Disclaimer: The contents of this article are of sole responsibility of the author(s). The Centre for Research on Globalization will not be responsible for any inaccurate or incorrect statement in this article. The Centre of Research on Globalization grants permission to cross-post Global Research articles on community internet sites as long the source and copyright are acknowledged together with a hyperlink to the original Global Research article. For publication of Global Research articles in print or other forms including commercial internet sites, contact: [email protected]
www.globalresearch.ca contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of "fair use" in an effort to advance a better understanding of political, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than "fair use" you must request permission from the
copyright owner.
